Breakthrough T1D Celebrates Exceptional Volunteers Impacting Type 1 Diabetes Research at Annual Conference

Breakthrough T1D Honors Volunteers at Annual Conference

In a celebration of leadership and community commitment, Breakthrough T1D (formerly JDRF) held its annual One Conference in New Orleans on February 26, 2026. The event showcased the significant impact of dedicated volunteers who have propelled the mission of advancing type 1 diabetes (T1D) research and advocacy.

During this exciting gathering, Breakthrough T1D announced five outstanding award recipients. These individuals and organizations have demonstrated exemplary dedication to the cause, contributing towards a future free of T1D.

Award Winners and Their Contributions

1. Carol and Erwin Lurie Award: Pete Cerar
The Carol and Erwin Lurie Award was presented to Pete Cerar for his unwavering commitment to Breakthrough T1D since his son's diagnosis in 2016. Serving as the Northern Ohio Chapter board president, he has taken the lead in strengthening chapter collaborations, enhancing local engagement, and growing leadership opportunities.

Cerar, who has participated in multiple fundraising rides, is passionate about building sustainable volunteer structures and fostering a strong community spirit. His proactive recruitment efforts and hands-on approach have significantly improved donor participation.

2. Dr. Gerald Fishbone Award: Deborah Nuzzo
Recognizing long-term dedication, the Dr. Gerald Fishbone Award was awarded to Deborah Nuzzo for her extensive volunteer service at Breakthrough T1D. Diagnosed with T1D 54 years ago, Nuzzo has contributed tirelessly, chairing numerous galas and leading fundraising campaigns that have marked significant financial milestones for the organization.

Her leadership has been a driving force behind successful chapter mergers and initiatives that emphasize community engagement and partnership, making her an invaluable asset to the organization.

3. Jim Tyree Award: Matt Varey
Presented to Matt Varey, the Jim Tyree Award acknowledges his impactful fundraising initiatives. Varey's involvement dates back to 2001, and despite not having a personal connection to T1D, his efforts in riding events and leadership roles highlight the spirit of advocacy and charity that Breakthrough T1D embodies. His recent Coast-to-Coast for Cures ride across Canada illustrates his commitment to raising awareness and capital for T1D research.

4. John Brady Award for Innovation: Larry Soler
Larry Soler was honored with the John Brady Award for his innovative approaches to advocacy. Since being diagnosed with T1D at the age of 22, Soler has played pivotal roles in legislative initiatives that resulted in substantial federal funding for T1D research, among various projects.

His participation in the Artificial Pancreas Project and consistent leadership has allowed Breakthrough T1D to push boundaries in T1D care and treatment, showcasing his foresight and dedication to the community.

5. Voice of Influence Award: Mattel
Finally, the Voice of Influence Award recognized Mattel for its initiative in creating the first-ever Barbie® doll with T1D, effectively advocating for greater awareness. By leveraging their platform, Mattel has created dialogue around T1D experiences, encouraging representation and visibility.

Conclusion

In closing, Dr. Aaron Kowalski, CEO of Breakthrough T1D, expressed gratitude towards all volunteers, affirming that their efforts are instrumental in building a future where T1D is no longer a barrier to a fulfilled life. With every award presented, the tangible impact of these individuals and organizations shines a light on the importance of community action in the fight against T1D.

The ongoing journey towards breakthroughs in research and treatment remains fueled by the fervor and dedication of volunteers who continue to push for changes that will ultimately transform the lives of those affected by this autoimmune condition. Breakthrough T1D stands committed to its mission as it collaborates with passionate individuals, advocates, and researchers alike, believing in a future void of T1D.